Detalhe da pesquisa
1.
Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant.
N Engl J Med
; 384(20): 1899-1909, 2021 05 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33951374
2.
Molnupiravir for the treatment of COVID-19 in immunocompromised participants: efficacy, safety, and virology results from the phase 3 randomized, placebo-controlled MOVe-OUT trial.
Infection
; 51(5): 1273-1284, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36648627
3.
Rilonacept for gout flare prevention during initiation of uric acid-lowering therapy: results from the PRESURGE-2 international, phase 3, randomized, placebo-controlled trial.
Rheumatology (Oxford)
; 52(7): 1285-92, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23485476
4.
Immunogenicity and safety of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine in people living with and without HIV-1 infection: a randomised, controlled, phase 2A/2B trial.
Lancet HIV
; 9(5): e309-e322, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35489376
5.
Physicochemical Properties of Biochars Produced from Biosolids in Victoria, Australia.
Int J Environ Res Public Health
; 15(7)2018 07 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29996556